Current understanding of CTLA-4: from mechanism to autoimmune diseases

MM Hossen, Y Ma, Z Yin, Y Xia, J Du… - Frontiers in …, 2023 - frontiersin.org
Autoimmune diseases (ADs) are characterized by the production of autoreactive
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …

Emerging cell and cytokine targets in rheumatoid arthritis

GR Burmester, E Feist, T Dörner - Nature Reviews Rheumatology, 2014 - nature.com
Despite major progress in the treatment of rheumatoid arthritis (RA), strong unmet medical
need remains, as only a minor proportion of patients reach sustained clinical remission. New …

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

AJ Czaja, MP Manns - Gastroenterology, 2010 - Elsevier
Autoimmune hepatitis (AIH) is characterized by chronic inflammation of the liver, interface
hepatitis (based on histologic examination), hypergammaglobulinemia, and production of …

HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function

R Zhao, JM Chinai, S Buhl… - Proceedings of the …, 2013 - National Acad Sciences
T-cell costimulation and coinhibition generated by engagement of the B7 family and their
receptor CD28 family are of central importance in regulating the T-cell response, making …

CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance

J Romo-Tena, D Gómez-Martín, J Alcocer-Varela - Autoimmunity reviews, 2013 - Elsevier
Abstract Cytotoxic T-Lymphocye Antigen 4 (CTLA-4) or CD152 is an inhibitory molecule that
plays a critical role in maintenance of tolerance to self-antigens. CTLA-4 is structurally as …

Fibroblast‐like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin‐11

S Kyung Chang, Z Gu, MB Brenner - Immunological reviews, 2010 - Wiley Online Library
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease affecting the joint
synovium. The normal synovium consists of a lining layer of fibroblast‐like synoviocytes …

[HTML][HTML] T-cell co-stimulation by CD28–CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development

MM Ewing, JC Karper, S Abdul, RCM De Jong… - International journal of …, 2013 - Elsevier
Objective T-cells are central to the immune response responsible for native atherosclerosis.
The objective of this study is to investigate T-cell contribution to post-interventional …

Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis

N Li, W Xu, Y Yuan, N Ayithan, Y Imai, X Wu, H Miller… - Scientific reports, 2017 - nature.com
V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-
checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on …

Prospective new biological therapies for rheumatoid arthritis

L Šenolt, J Vencovský, K Pavelka, C Ospelt, S Gay - Autoimmunity reviews, 2009 - Elsevier
Advances in the current knowledge of pathogenetic mechanisms of rheumatoid arthritis
have contributed to the development of biological therapy, and translated research findings …

Abatacept mechanism of action: concordance with its clinical profile

G Herrero-Beaumont, MJM Calatrava… - … Clínica (English Edition), 2012 - Elsevier
The double and simultaneous molecular interaction between antigen-presentig cells (APC)
and T lymphocytes is essential for the optimal activation of the immunological response and …